Is budesonide oral suspension (Eohilia) safe for use in children?

Budesonide oral suspension (Eohilia) is an oral syrup preparation specially used to treat eosinophilic esophagitis (EoE). Its main active ingredient is budesonide, a corticosteroid that can effectively reduce esophageal inflammatory response. Eohilia acts directly on the esophageal mucosa, inhibits the activity of local inflammatory cells, and relieves symptoms such as dysphagia, food obstruction, and retrosternal pain caused by eosinophilic esophagitis, thereby improving the quality of life of children and adolescents.

Clinically, Eohilia is mainly suitable for children and adolescent patients aged 11 and above. This is based on considerations of drug safety, dosage management and existing clinical research data. The local anti-inflammatory effect of the drug can reduce the risk of adverse effects of systemic corticosteroids, especially in patients who require long-term maintenance therapy. However, parents and medical staff should strictly follow the doctor's prescription instructions during use, pay attention to the dosage, frequency of taking, and observation during use.

When using budesonide oral suspension, children should avoid swallowing too fast or eating other foods immediately to ensure that the drug fully contacts the esophageal mucosa and takes effect. At the same time, regular follow-up is required to monitor the recovery of esophageal mucosa and evaluate the effect of treatment. Although the drug is relatively safe when applied topically, long-term or excessive use may still cause minor systemic side effects, such as corticosteroid-related effects. Therefore, following the individualized treatment plan from a professional physician is the key to ensuring the safety and efficacy of medication in children.

In short,Eohilia provides a specialized treatment option for eosinophilic esophagitis for children and adolescents aged 11 years and above. It can improve dysphagia and esophageal inflammation through local anti-inflammatory effects while reducing the risk of systemic side effects, but it needs to be used rationally under the guidance of a doctor.

Reference materials:https://www.drugs.com